CLINICAL_TRIALS
trial_result
· 2025-04-29
Clinical Trial Update: Phase 2 Study of HEC88473 Injection in Subjects With Type 2 Diabetes Mellitus [Phase 2]
Summary
Phase 2 study of HEC88473 Injection in subjects with Type 2 Diabetes Mellitus has been completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Dongguan HEC Biopharmaceutical R&D Co., Ltd. | Conditions: Type 2 Diabetes | Phase 2 | Status: COMPLETED